Literature DB >> 22461177

Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats.

Sarah Richards Novotny1, Kedra Wallace, Judith Heath, Janae Moseley, Pushpinder Dhillon, Abram Weimer, Gerd Wallukat, Florian Herse, Katrin Wenzel, James N Martin, Ralf Dechend, Babbette Lamarca.   

Abstract

Hypertension in rats with chronic placental ischemia (reduced uterine perfusion pressure, RUPP) is associated with elevated inflammatory cytokines, agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and CD4(+) T cells; all of which are elevated in preclamptic women. Additionally, we have shown that adoptive transfer of RUPP CD4(+) T cells increases blood pressure, inflammatory cytokines, and sFlt-1. The objective of this study was to determine the long-term effects of RUPP CD4(+) T cells on AT1-AA, renal and systemic hemodynamics in pregnant rats. To answer this question CD4(+) T splenocytes were magnetically isolated on day 19 of gestation from control RUPP and normal pregnant (NP) rats and injected into a new group of NP rats at day 13 of gestation. On day 19 of gestation mean arterial pressure (MAP) and renal function (glomerular filtration rates, GFR) were analyzed and serum collected for AT1-AA analysis. To determine a role for AT1-AA to mediate RUPP CD4(+) T cell-induced blood pressure increases, MAP was analyzed in a second group of rats treated with AT1 receptor blockade losartan (10 mg·kg(-1)·day(-1)) and in a third group of rats treated with rituximab, a B cell-depleting agent (250 mg/kg) we have shown previously to decrease AT1-AA production in RUPP rats. MAP increased from 101 ± 2 mmHg NP to 126 ± 2 mmHg in RUPP rats (P < 0.001) and to 123 ± 1 mmHg in NP rats injected with RUPP CD4(+) T cells (NP+RUPP CD4(+)T cells) (P < 0.001). Furthermore, GFR decreased from 2.2 ml/min (n = 7) in NP rats to 1.0 ml/min (n = 5) NP+RUPP CD4(+)T cell. Circulating AT1-AA increased from 0.22 ± 0.1 units in NP rats to 13 ± 0.7 (P < 0.001) units in NP+RUPP CD4(+)T cell-treated rats but decreased to 8.34 ± 1 beats/min in NP+RUPP CD4(+) T cells chronically treated with rituximab. Hypertension in NP+RUPP CD4(+)T cell group was attenuated by losartan (102 ± 4 mmHg) and with B cell depletion (101 ± 5 mmHg). Therefore, we conclude that one mechanism of hypertension in response to CD4(+) T lymphocytes activated during placental ischemia is via AT1 receptor activation, potentially via AT1-AA during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461177      PMCID: PMC3362148          DOI: 10.1152/ajpregu.00623.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  24 in total

1.  The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.

Authors:  Marc R Parrish; Sydney R Murphy; Sarah Rutland; Kedra Wallace; Katrin Wenzel; Gerd Wallukat; Sharon Keiser; Lillian Fournier Ray; Ralf Dechend; James N Martin; Joey P Granger; Babbette LaMarca
Journal:  Am J Hypertens       Date:  2010-04-29       Impact factor: 2.689

2.  Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.

Authors:  Athar H Siddiqui; Roxanna A Irani; Sean C Blackwell; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

3.  Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.

Authors:  Babbette LaMarca; Kedra Wallace; Florian Herse; Gerd Wallukat; James N Martin; Abram Weimer; Ralf Dechend
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

5.  CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy.

Authors:  Kedra Wallace; Sarah Richards; Pushpinder Dhillon; Abram Weimer; Eva-stina Edholm; Eva Bengten; Melanie Wilson; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2011-04-04       Impact factor: 10.190

6.  Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression.

Authors:  Jeffrey S Gilbert; Sara A B Gilbert; Marietta Arany; Joey P Granger
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

7.  Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice.

Authors:  Cissy C Zhou; Yujin Zhang; Roxanna A Irani; Hong Zhang; Tiejuan Mi; Edwina J Popek; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Nat Med       Date:  2008-07-27       Impact factor: 53.440

8.  Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.

Authors:  Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A Babcock; Hunter Berry; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

9.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

10.  Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.

Authors:  Cissy Chenyi Zhou; Shakil Ahmad; Tiejuan Mi; Shahrzad Abbasi; Lingwei Xia; Mary-Clare Day; Susan M Ramin; Asif Ahmed; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

View more
  48 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

Review 3.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

4.  Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats.

Authors:  Denise C Cornelius; Javier Castillo; Justin Porter; Lorena M Amaral; Nathan Campbell; Adrienne Paige; Alexia J Thomas; Ashlyn Harmon; Mark W Cunningham; Kedra Wallace; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

Review 5.  Elucidating immune mechanisms causing hypertension during pregnancy.

Authors:  Babbette LaMarca; Denise Cornelius; Kedra Wallace
Journal:  Physiology (Bethesda)       Date:  2013-07

6.  Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia.

Authors:  Lukasz Przybyl; Tarek Ibrahim; Nadine Haase; Michaela Golic; Julianna Rugor; Friedrich C Luft; Ivo Bendix; Meray Serdar; Gerd Wallukat; Anne Cathrine Staff; Dominik N Müller; Thomas Hünig; Ursula Felderhoff-Müser; Florian Herse; Babette LaMarca; Ralf Dechend
Journal:  Hypertension       Date:  2015-04-06       Impact factor: 10.190

Review 7.  The immune system in hypertension.

Authors:  Daniel W Trott; David G Harrison
Journal:  Adv Physiol Educ       Date:  2014-03       Impact factor: 2.288

8.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

9.  Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.

Authors:  Mark W Cunningham; Jan M Williams; Lorena Amaral; Nathan Usry; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

Review 10.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.